Furthermore, we found increased levels of GR1+ MDSCs and CD4+FOXP3+ Tregs, a frequent occurrence in AML patients [17–20, 40] (Supplementary Fig S1A, B), but no difference in T cell frequency (Supplementary Fig S1C). The gene discussed is FOXP3; the disease is acute myeloid leukemia.